CXC chemokines in the pathogenesis of pulmonary disease and pharmacological relevance

K Komolafe, M Pacurari - International journal of inflammation, 2022 - Wiley Online Library
Chemokines and their receptors play important roles in the pathophysiology of many
diseases by regulating the cellular migration of major inflammatory and immune players …

Recent emerging immunological treatments for primary brain tumors: focus on chemokine-targeting immunotherapies

A Ardizzone, R Basilotta, A Filippone, L Crupi, M Lanza… - Cells, 2023 - mdpi.com
Primary brain tumors are a leading cause of death worldwide and are characterized by
extraordinary heterogeneity and high invasiveness. Current drug and radiotherapy therapies …

Genome-wide association study of COVID-19 outcomes reveals novel host genetic risk loci in the Serbian population

M Zecevic, N Kotur, B Ristivojevic, V Gasic… - Frontiers in …, 2022 - frontiersin.org
Host genetics, an important contributor to the COVID-19 clinical susceptibility and severity,
currently is the focus of multiple genome-wide association studies (GWAS) in populations …

Recent clinical findings on the role of kinase inhibitors in COVID-19 management

Z Malekinejad, A Baghbanzadeh, A Nakhlband… - Life Sciences, 2022 - Elsevier
The highly pathogenic, novel coronavirus disease (COVID-19) outbreak has emerged as a
once-in-a-century pandemic with poor consequences, urgently calling for new therapeutics …

[HTML][HTML] Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro

HR Jonsdottir, D Siegrist, T Julien, B Padey… - Biomedicine & …, 2022 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic with unprecedented economic and societal impact. Currently, several …

Distinct expression patterns of interleukin-22 receptor 1 on blood hematopoietic cells in SARS-CoV-2 infection

N Albayrak, C Orte Cano, S Karimi, D Dogahe… - Frontiers in …, 2022 - frontiersin.org
The new pandemic virus SARS-CoV-2 is characterized by uncontrolled hyper-inflammation
in severe cases. As the IL-22/IL-22R1 axis was reported to be involved in inflammation …

Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A …

J Saikarthik, I Saraswathi, A Alarifi, AA Al-Atram… - PeerJ, 2022 - peerj.com
Persistence of symptoms beyond the initial 3 to 4 weeks after infection is defined as post-
acute COVID-19 syndrome (PACS). A wide range of neuropsychiatric symptoms like anxiety …

[HTML][HTML] From COVID-19 to sarcoidosis: how similar are these two diseases?

M Zhao, C Tian, S Cong, X Di, K Wang - Frontiers in Immunology, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), leads to the dysregulation of the immune system …

[HTML][HTML] The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients

TO Filgueira, PRC Carvalho… - Frontiers in …, 2023 - frontiersin.org
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high
release of pro-inflammatory chemokines and cytokines, leading to severe systemic …

Mast cell activation syndrome in COVID‐19 and female reproductive function: theoretical background vs. accumulating clinical evidence

D Szukiewicz, P Wojdasiewicz… - Journal of …, 2022 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19), a pandemic disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, can affect almost all systems …